Testosterone Undecanoate Replacement Therapy in Boys With Pubertal Delay or Confirmed Hypogonadism

RecruitingOBSERVATIONAL
Enrollment

27

Participants

Timeline

Start Date

March 1, 2022

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Delayed PubertyMale Hypogonadism
Interventions
DRUG

Testosterone Undecanoate

Testosterone undecanoate (1000 mg/4 ml) will be administered at a dose of 1 ml every 12 weeks for 6 months, 2 ml every 12 weeks for 6 months, 3 ml every 12 weeks for 6 months and 4 ml every 12 weeks for 6 months.

Trial Locations (1)

1425

RECRUITING

Rodolfo Rey, Buenos Aires

All Listed Sponsors
collaborator

National Agency for Scientific and Technological Promotion, Argentina

OTHER

lead

Hospital de Niños R. Gutierrez de Buenos Aires

OTHER